Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Coronary risk estimation in Spain using a calibrated Framingham function].

Jaume Marrugat1, Pascual Solanas, Ralph D'Agostino

  • 1Unitat de Lípids i Epidemiologia Cardiovascular. Institut Municipal d'Investigació Mèdica (IMIM). Barcelona. Universitat Autònoma de Barcelona. Spain. jmarrugat@imim.es

Revista Espanola De Cardiologia
|March 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in Long COVID Prevalence Over One year After the Acute Phase, and Related Risk Factors. The GINA-COVID Cohort Study.

International journal of women's health·2026
Same author

Ethics and Data in Precision Nutrition: A Roadmap for Responsible Innovation.

The Journal of nutrition·2026
Same author

Aerobic Fitness and Health-Related Phenotypes: A Two-Stage Phenome-Wide Mendelian Randomization Study.

Medicine and science in sports and exercise·2026
Same author

Early Response to a Behavioral Community-Based Educational Intervention on Cardiovascular Risk Profile and Well-Being.

JACC. Advances·2026
Same author

Utilizing existing test results to improve primary prevention in patients with subclinical coronary atherosclerosis: The USE-IT study.

American journal of preventive cardiology·2026
Same author

Declining 28-day population myocardial infarction case-fatality trends in Catalonia, Spain: an analysis of the possible contribution of emergency management network.

European journal of public health·2026
Same journal

[Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group. Response].

Revista espanola de cardiologia·2023
Same journal

[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group].

Revista espanola de cardiologia·2023
Same journal

[Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment].

Revista espanola de cardiologia·2022
Same journal

[Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine].

Revista espanola de cardiologia·2022
See all related articles

Calibrating the Framingham coronary heart disease (CHD) risk function for Spain improves accuracy in primary prevention. New charts show more precise CHD risk for the Spanish population, accounting for local risk factors and HDL cholesterol levels.

Area of Science:

  • Cardiovascular Epidemiology
  • Preventive Cardiology
  • Biostatistics

Context:

  • The Framingham coronary heart disease (CHD) risk functions are widely used but may overestimate risk in populations with lower incidence rates, such as Spain.
  • Accurate risk assessment is crucial for effective primary prevention strategies.

Purpose:

  • To calibrate the Framingham CHD risk function for the Spanish population.
  • To present color-coded charts estimating 10-year CHD risk based on local prevalence of risk factors and high-density lipoprotein (HDL) cholesterol levels.

Summary:

  • The Framingham functions were recalibrated using Spanish epidemiological data, including CHD risk factor prevalence and incidence.
  • High-density lipoprotein (HDL) cholesterol levels significantly impacted risk: <35 mg/dL increased risk by ~50%, while >60 mg/dL reduced it by ~50%.

Related Experiment Videos

  • The calibrated charts revealed a higher proportion of individuals with >9% 10-year CHD risk and a lower proportion with >19% risk compared to the original Framingham charts.

    • Impact:

    • The calibrated Framingham function provides a more accurate tool for estimating overall CHD risk in the Spanish population for primary prevention.
    • This recalibration aids clinicians in identifying individuals who would benefit most from preventive interventions.
    • Further validation and development of population-specific risk functions are recommended.